PANG Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pangaea Oncology SA

Watchlist Manager

Watchlist

Price: 1.43 EUR Market Closed

Market Cap: €51.8m

	Pangaea Oncology SA MAD:PANG	ES
A	Action Square Co Ltd KOSDAQ:205500	KR

Profitability Summary

Pangaea Oncology SA's profitability score is 21/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

61%

Gross Margin is Increasing

41% > 62%

Negative Operating Margin

-26%

Negative 3Y Average Operating Margin

-24%

Operating Margin is Increasing

-67% > -26%

Negative Net Margin

-25%

Negative 3Y Average Net Margin

-29%

Net Margin is Increasing

-62% > -25%

Negative Free Cash Flow Margin

-21%

Negative 3Y Average Free Cash Flow Margin

-31%

Free Cash Flow Margin is Increasing

-80% > -21%

Negative ROE

-17%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-13%

ROIC is Increasing

-14% > -13%

View All

Hide

Collapse

21 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.